Literature DB >> 2529785

Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure.

M M Redfield1, B S Edwards, D M Heublein, J C Burnett.   

Abstract

The renal response to atrial natriuretic factor (ANF) has been shown to be blunted in several experimental models of acute and chronic congestive heart failure. The mechanism responsible for this blunted response has been postulated to be activation of the renin-angiotensin system with associated potent antinatriuretic effects and/or the reduction in renal perfusion pressure (RPP) characteristic of heart failure. The present study was designed to examine the relative role of these two factors in mediating the blunted response to ANF in a model of acute low output heart failure produced by thoracic inferior vena cava constriction (TIVCC) in the anesthetized dog. TIVCC was produced in five groups of dogs. In group 1, ANF was infused after TIVCC to document the blunted natriuretic response. In group 2, ANF was infused after TIVCC in the presence of blockade of intrarenal angiotensin II (ANG II) by the intrarenal infusion of saralasin (Sar) at a dose without systemic effects. In group 3, ANF was infused after TIVCC in the presence of restoration of RPP by infusion of ANG II at a dose titrated to restore RPP to the level present before TIVCC. In group 4, ANF was infused in the presence of restoration of RPP with ANG II and blockade of intrarenal ANG II with Sar. Group 5 served as an additional control group where the effect of ANG II and Sar in TIVCC was examined in the absence of ANF. Restoration of RPP but not blockade of intrarenal ANG II resulted in a restoration of the response of sodium excretion and glomerular filtration rate to ANF. ANG II plus Sar in the absence of ANF did not produce a natriuresis. We conclude that RPP, more than intrarenal ANG II, modulates the blunted renal response to ANF observed in this model of acute low-output heart failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529785     DOI: 10.1152/ajpregu.1989.257.4.R917

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.

Authors:  D A Sica; T W Gehr
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 2.  Aldosterone receptor blockade in the management of heart failure.

Authors:  Emiliano A Palmieri; Bernadette Biondi; Serafino Fazio
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

3.  Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.

Authors:  Horng H Chen; Omar F AbouEzzeddine; Kevin J Anstrom; Michael M Givertz; Bradley A Bart; G Michael Felker; Adrian F Hernandez; Kerry L Lee; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

4.  Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure.

Authors:  Horng H Chen; Alessandro Cataliotti; John A Schirger; Fernando L Martin; Lynn K Harstad; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

Review 5.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

6.  Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.

Authors:  K B Margulies; M A Perrella; L J McKinley; J C Burnett
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction.

Authors:  Theophilus E Owan; Horng H Chen; Robert P Frantz; Barry L Karon; Wayne L Miller; Richard J Rodeheffer; David O Hodge; John C Burnett; Margaret M Redfield
Journal:  J Card Fail       Date:  2008-05       Impact factor: 5.712

8.  Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs.

Authors:  M A Perrella; K B Margulies; C M Wei; L L Aarhus; D M Heublein; J C Burnett
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 9.  Natriuretic peptides in the pathophysiology of congestive heart failure.

Authors:  H H Chen; J C Burnett
Journal:  Curr Cardiol Rep       Date:  2000-05       Impact factor: 3.955

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.